All In Biotech

Free tool

FAERS Monitor: Epivir

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 19, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020596 or its brand name (Epivir, Lamivudine). Reports on generic versions are filed under their own applications.

Reports

30,839

Serious

29,623

96% of reports

Hospitalization

9,361

Death reported

4,112

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • foetal exposure during pregnancy2,040
  • drug resistance1,960
  • virologic failure1,960
  • drug interaction1,871
  • pathogen resistance1,774
  • viral mutation identified1,671
  • depression1,343
  • pyrexia1,279
  • drug ineffective1,165
  • anaemia1,126
  • pain1,122
  • nausea1,079
  • treatment failure1,028
  • vomiting1,023
  • anxiety987

Reports by year received

View as table
YearReports
20041,143
20051,218
20061,265
20071,049
20081,114
20091,084
2010763
2011671
2012757
2013670
2014805
20151,613
20162,262
20172,126
20182,122
20192,247
20202,541
20211,842
20221,853
20231,697
2024864
2025718
2026401

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,023,320 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
viral mutation identifiedSignal1,671565.1530.1514,230
virologic failureSignal1,960390.3369.7483,893
pathogen resistanceSignal1,774164.5156.4232,257
drug resistanceSignal1,96056.353.898,330
foetal exposure during pregnancySignal2,04017.516.831,106
treatment failureSignal1,0288.68.16,795
drug interactionSignal1,8718.17.811,638
anaemiaSignal1,1264.03.82,586
depressionSignal1,3434.03.83,089
pyrexiaSignal1,2792.52.41,194
anxietySignal9872.42.2788
vomiting1,0231.51.4165
pain1,1221.21.256
nausea1,0790.90.96
drug ineffective1,1650.60.6325

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.